Translation of human pluripotent stem cells into cell therapies will require the development of standardized tests for product consistency, stability, tumorigenicity, toxicity and immunogenicity.
References
Bach, F.H., Albertini, R.J., Joo, P., Anderson, J.L. & Bortin, M.M. Lancet 2, 1364–1366 (1968).
Gatti, R.A., Meuwissen, H.J., Allen, H.D., Hong, R. & Good, R.A. Lancet 2, 1366–1369 (1968).
Jaenisch, R. & Young, R. Cell 132, 567–582 (2008).
Yu, J. & Thomson, J.A. Genes Dev. 22, 1987–1997 (2008).
Hentze, H., Graichen, R. & Colman, A. Trends Biotechnol. 25, 24–32 (2007).
Preti, R.A. Nat. Biotechnol. 23, 801–804 (2005).
Thomson, J.A. et al. Science 282, 1145–1147 (1998).
Crook, J. et al. Cell Stem Cell 1, 490–494 (2007).
Adewumi, O. et al. Nat. Biotechnol. 25, 803–816 (2007).
Kroon, E. et al. Nat. Biotechnol. 26, 443–452 (2008).
Osafune, K. et al. Nat. Biotechnol. 26, 313–315 (2008).
Bhattacharya, B. et al. Blood 103, 2956–2964 (2004).
Ramalho-Santos, M., Yoon, S., Matsuzaki, Y., Mulligan, R.C. & Melton, D.A. Science 298, 597–600 (2002).
Richards, M., Tan, S.P., Tan, J.H., Chan, W.K. & Bongso, A. Stem Cells 22, 51–64 (2004).
Sato, N. et al. Dev. Biol. 260, 404–413 (2003).
Muller, F.J. et al. Nature 455, 401–405 (2008).
Nistor, G.I., Totoiu, M.O., Haque, N., Carpenter, M.K. & Keirstead, H.S. Glia 49, 385–396 (2005).
Chambers, S.M. et al. Nat. Biotechnol. 27, 275–280 (2009).
Laflamme, M.A. et al. Nat. Biotechnol. 25, 1015–1024 (2007).
Yang, L. et al. Nature 7194, 524–528 (2008).
Spivakov, M. & Fisher, A.G. Nat. Rev. Genet. 8, 263–271 (2007).
Wu, H. & Sun, Y.E. Pediatr. Res. 59, 21R–25R (2006).
Flynn, C.M. & Kaufman, D.S. Blood 109, 2688–2692 (2007).
Rosler, E.S. et al. Dev. Dyn. 229, 259–274 (2004).
Brimble, S.N. et al. Stem Cells Dev. 13, 585–597 (2004).
Draper, J.S. et al. Nat. Biotechnol. 22, 53–54 (2004).
Rugg-Gunn, P.J., Ferguson-Smith, A.C. & Pedersen, R.A. Nat. Genet. 37, 585–587 (2005).
Sun, B.W. et al. Hum. Mol. Genet. 15, 65–75 (2006).
Maitra, A. et al. Nat. Genet. 37, 1099–1103 (2005).
Lefort, N. et al. Nat. Biotechnol. 26, 1364–1366 (2008).
Spits, C. et al. Nat. Biotechnol. 26, 1361–1363 (2008).
Sun, X. et al. Human Reproduction 23, 2185–2193 (2008).
Rugg-Gunn, P.J., Ferguson-Smith, A.C. & Pedersen, R.A. Hum. Mol. Genet. 16, R243–251 (2007).
Pannetier, M. & Feil, R. Trends Biotechnol. 25, 556–562 (2007).
Hoffman, L.M. et al. Stem Cells 23, 1468–1478 (2005).
Dhara, S.K. & Benvenisty, N. Nucleic Acids Res. 32, 3995–4002 (2004).
Ball, M.P. et al. Nat. Biotechnol. 27, 361–368 (2009).
Deng, J. et al. Nat. Biotechnol. 27, 353–360 (2009).
Kondziolka, D. et al. Neurology 55, 565–569 (2000).
Kondziolka, D. et al. J. Neurosurg. 103, 38–45 (2005).
Mostert, M.M. et al. Cancer Genet. Cytogenet. 87, 95–102 (1996).
Kleppner, S.R., Robinson, K.A., Trojanowski, J.Q. & Lee, V.M. J. Comp. Neurol. 357, 618–632 (1995).
Ulbright, T.M. Mod. Pathol. 18 Suppl 2, S61–S79 (2005).
Andrews, P.W. Biochim. Biophys. Acta 948, 17–36 (1988).
Ginis, I. et al. Dev. Biol. 269, 360–380 (2004).
Watanabe, K. et al. Nat. Biotechnol. 25, 681–686 (2007).
Harb, N., Archer, T.K. & Sato, N. PLoS One 3, e3001 (2008).
Martin-Ibanez, R. et al. Hum. Reprod. 23, 2744–2754 (2008).
Cooke, M.J., Stojkovic, M. & Przyborski, S.A. Stem Cells Dev. 15, 254–259 (2006).
Shih, C.C., Forman, S.J., Chu, P. & Slovak, M. Stem Cells Dev. 16, 893–902 (2007).
Roy, N.S. et al. Nat. Med. 12, 1259–1268 (2006).
Brederlau, A. et al. Stem Cells 24, 1433–1440 (2006).
Leor, J. et al. Heart 93, 1278–1284 (2007).
Caspi, O. et al. J. Am. Coll. Cardiol. 50, 1884–1893 (2007).
Cloutier, F., Siegenthaler, M.M., Nistor, G. & Keirstead, H.S. Regen. Med. 1, 469–479 (2006).
Ravindran, G., Ramnath, R.L., Rao, H.S. & Viswanathan, C. Biochem. Biophys. Res. Commun. 373, 258–264 (2008).
Drukker, M. et al. Proc. Natl. Acad. Sci. USA 99, 9864–9869 (2002).
Li, L. et al. Stem Cells 22, 448–456 (2004).
Swijnenburg, R.J. et al. Proc. Natl. Acad. Sci. USA 105, 12991–12996 (2008).
Taylor, C.J. et al. Lancet 366, 2019–2025 (2005).
Rao, M.S. & Auerbach, J.M. Lancet 367, 650 (2006).
Takahashi, K. & Yamanaka, S. Cell 126, 663–676 (2006).
Yu, J. et al. Science 318, 1917–1920 (2007).
Okita, K., Ichisaka, T. & Yamanaka, S. Nature 448, 313–317 (2007).
Statfeld, M. et al. Science 322, 945–949 (2008).
Okita, K., Nakagawa, M., Hyenjong, H., Ichisaka, T. & Yamanaka, S. Science 322, 949–953 (2008).
Yu, J. et al. Science 324, 797–801 (2009).
Woltjen, K. et al. Nature 458, 766–770 (2009).
Soldner, F. et al. Cell 136, 964–977 (2009).
Zhou, H. et al. Cell Stem Cell 4, 381–384 (2009).
Kim, D. et al. Cell Stem Cell 4, 472–476 (2009).
Takahashi, K. et al. Cell 131, 861–872 (2007).
Aasen, T. et al. Nat. Biotechnol. 26, 1276–1284 (2008).
Loh, Y.H. et al. Blood 113, 5476–5479 (2009).
Aoi, T. et al. Science 321, 699–702 (2008).
Rao, M. & Condic, M.L. Stem Cells Dev. 17, 1–10 (2008).
Condic, M.L. & Rao, M. Stem Cells 26, 2753–2758 (2008).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Carpenter, M., Frey-Vasconcells, J. & Rao, M. Developing safe therapies from human pluripotent stem cells. Nat Biotechnol 27, 606–613 (2009). https://doi.org/10.1038/nbt0709-606
Issue Date:
DOI: https://doi.org/10.1038/nbt0709-606
- Springer Nature America, Inc.
This article is cited by
-
Exploring the promising potential of induced pluripotent stem cells in cancer research and therapy
Molecular Cancer (2023)
-
Biomedical polymers: synthesis, properties, and applications
Science China Chemistry (2022)
-
Preclinical Studies and Clinical Prospects of Wharton’s Jelly-Derived MSC for Treatment of Acute Radiation Syndrome
Current Stem Cell Reports (2021)
-
Robust detection of undifferentiated iPSC among differentiated cells
Scientific Reports (2020)
-
Transforming healthcare through regenerative medicine
BMC Medicine (2016)